321 - State-of-the-Art Session
Challenges and advances in transplant immunosuppression
Tuesday September 13, 2022
|
14:30 to 16:00
Room: C2
Track: Transplantation Immunosuppression
Description
For attending this session, you can claim 1.5 EACCME credits
Learning Objectives
After this session, the participants should be able to:
- Be aware how to personalize IS using pharmacogenomics
- Know the list ofimmunosuppresives drugs present in the pipeline
- Be aware of various ways tomanage IS when a cancer is diagnosed
Presentations
Dr. Pamala A Jacobson, United States
Pharmacogenomics: a promise of personalized medication management
Dr. Ilkka Helantera, Finland
The immunosuppressive therapy pipeline: what is really out there?
